This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Neuromodulation Devices: World Market Prospects 2013-2023

List of TablesTable 3.1 Net Sales ($bn) and Market Shares (%) Of The Global Medical Market, By Sector, 2011Table 3.2 The Global Neurology Devices Market: Net Sales ($bn) and Market Shares (%), By Speciality, 2011Table 3.3 The Global Neuromodulation Devices Market: Net Sales ($bn) and Market Shares (%), By Technology, 2011Table 3.4 The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2011-2017Table 3.5 The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2017-2023Table 4.1 Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017Table 4.2 Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023Table 5.1 Deep Brain Stimulation: Market Forecast ($bn), 2011-2017Table 5.2 Deep Brain Stimulation: Market Forecast ($bn), 2017-2023Table 6.1 Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017Table 6.2 Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023Table 7.1 Neuromodulation Devices: Net Sales ($bn) and Market Shares (%), By Company, 2011Table 7.2 Medtronic: Net Sales ($bn) and Market Shares (%), By Segment, 2011Table 7.3 Restorative Therapies: Net Sales ($bn) and Market Shares (%), By Product Line, 2011Table 7.4 Medtronic: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.5 SJM: Net Sales ($bn) and Market Shares (%), By Segment, 2011Table 7.6 CRM/NMD Segment: Net Sales ($bn) and Market Shares (%), By Product Group, 2011Table 7.7 SJM: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.8 Boston Scientific: Net Sales ($bn) and Market Shares (%), By Product Category, 2011Table 7.9 Boston Scientific: Net Sales ($bn) and Market Shares (%), By Region, 2011Table 7.10 Cyberonics: Net Sales ($m) and Market Shares (%), By Region, 2011Table 7.11 Other Companies Operating in The Global Neuromodulation Device Market, 2012Table 8.1 Neuromodulation Devices: Sales ($bn) and Market Shares (%), By Country/Region, 2011Table 8.2 Neuromodulation Devices Market Forecast ($bn), By Country/Region, 2011-2023Table 8.3 The Leading European Neuromodulation Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%), By Region, 2011Table 8.4 The European Neuromodulation Devices Market Forecast ($bn), By Region, 2011-2023Table 9.1 Neuromodulation Devices: Industry Pipeline, 2012Table 10.1 SWOT Analysis of the Neuromodulation Devices Market, 2012Table 12.1 Neuromodulation Devices Market Forecast ($bn) By Technology, in 2017, 2019 and 2023

List of FiguresFigure 3.1 Market Shares (%) Of The Global Medical Device Market, By Sector, 2011Figure 3.2 The Global Neurology Devices Market: Market Shares (%), By Speciality, 2011Figure 3.3 The Global Neuromodulation Devices Market: Net Sales ($bn), By Technology, 2011Figure 3.4 The Global Neuromodulation Devices Market: Market Shares (%), By Technology, 2011Figure 3.5 The Global Neuromodulation Devices Market Forecast, 2011-2017Figure 3.6 The Global Neuromodulation Devices Market Forecast, 2017-2023Figure 4.1 Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017Figure 4.2 Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023Figure 5.1 Deep Brain Stimulation: Market Forecast ($bn), 2011-2017Figure 5.2 Deep Brain Stimulation: Market Forecast ($bn), 2017-2023Figure 6.1 Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017Figure 6.2 Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023Figure 7.1 Neuromodulation Devices: Net Sales ($bn), By Company, 2011Figure 7.2 Neuromodulation Devices: Market Shares (%), By Company, 2011Figure 7.3 Medtronic: Market Shares (%), By Segment, 2011Figure 7.4 Restorative Therapies: Net Sales ($bn), By Product Line, 2011Figure 7.5 Restorative Therapies: Market Shares (%), By Product Line, 2011Figure 7.6 Medtronic: Net Sales ($bn), By Region, 2011Figure 7.7 Medtronic: Market Shares (%), By Region, 2011Figure 7.8 SJM: Market Shares (%), By Segment, 2011Figure 7.9 CRM/NMD Segment: Market Shares (%), By Product Group, 2011Figure 7.10 SJM: Net Sales ($bn), By Region, 2011Figure 7.11 SJM: Market Shares (%), By Region, 2011Figure 7.12 Boston Scientific: Net Sales ($bn), By Product Category, 2011Figure 7.13 Boston Scientific: Market Shares (%), By Product Category, 2011Figure 7.14 Boston Scientific: Net Sales ($bn), By Region, 2011Figure 7.15 Boston Scientific: Market Shares (%), By Region, 2011Figure 7.16 Cyberonics: Net Sales ($m), By Quarter, 2011Figure 7.17 Cyberonics: Net Sales ($m), By Region, 2011Figure 7.18 Cyberonics: Market Shares (%), By Region, 2011Figure 8.1 Neuromodulation Devices: Net Sales ($bn), By Region, 2011Figure 8.2 Neuromodulation Devices: Market Shares (%), By Region, 2011Figure 8.3 The US Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.4 The European Neuromodulation Devices Market: Net Sales ($bn), By Region, 2011Figure 8.5 The European Neuromodulation Devices Market: Market Shares (%), By Region, 2011Figure 8.6 The European Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.7 The German Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.8 The French Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.9 The Italian Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.10 The Spanish Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.11 The UK Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.12 The Japanese Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.13 The Chinese Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 8.14 The Indian Neuromodulation Devices Market Forecast ($bn), 2011-2023Figure 12.1 Projected Neuromodulation Devices Market Size for 2017, 2019 and 2023, By TechnologyFigure 12.2 Projected Total Neuromodulation Devices Market Size ($bn) in 2011, 2017, 2019 and 2023

Companies ListedAdvanced BionicsAleva NeurotherapeuticsApnex MedicalAtrotechAutonomic TechnologiesAvery BiomedicalBioControl MedicalBoston ScientificCerbomedCervel NeurotechCVRxCyberonicsElectroCoreEnteroMedicsFunctional Neuromodulation ImThera MedicalInspire Medical SystemsIntelect MedicalIntraPaceMed-ElMedtronicMetaCureMicroTransponderNeurelecNeuroneticsNeuronix MedicalNeuroPaceNeuros MedicalNeurosigmaNeurotech GroupNeurowave Medical TechnologiesNevroRespicardiaRetina Implant AGRS Medical/Vertis NeuroscienceSecond Sight Medical ProductsSpinal ModulationSPR TherapeuticsSt. Jude MedicalSynapse BiomedicalUroplasty

Government Agencies and Other Organisations Mentioned in This ReportFDAWHOUNEU

To order this report: Pathology Industry: Neuromodulation Devices: World Market Prospects 2013-2023

__________________________Contact Clare: clare@reportlinker.com US:(339) 368 6001 Intl:+1 339 368 6001

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
2 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,356.87 +288.00 1.69%
S&P 500 2,012.89 +40.15 2.04%
NASDAQ 4,644.3120 +96.4780 2.12%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs